Clozapine and cardiometabolic health in chronic schizophrenia: correlations and consequences in a clinical context.

@article{Malhi2010ClozapineAC,
  title={Clozapine and cardiometabolic health in chronic schizophrenia: correlations and consequences in a clinical context.},
  author={Gin S. Malhi and Danielle Adams and Janice Plain and Carissa M. Coulston and Michael L. Herman and G. Wiest Walter},
  journal={Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists},
  year={2010},
  volume={18 1},
  pages={
          32-41
        }
}
OBJECTIVE The aim of this study was to identify the prevalence of metabolic syndrome and its putative precursors in a naturalistic study of non-acute inpatients at a psychiatric hospital. METHOD Anthropometric and biochemical data collected from the hospital's annual cardiometabolic survey, along with information about prescribed medications, were used to assess the prevalence and predictors of physical health problems in patients with schizophrenia. RESULTS Of the 167 patients included in… CONTINUE READING
BETA